Summary
An analysis of private market research estimates markedly different US implant uptake depending on which audiometric candidacy definition is used.
Key findings
- The publisher abstract reports cumulative US implantation in 170,252 people, involving 240,056 devices, as of 2015.
- Utilization was approximately 12.7% among people meeting traditional audiometric criteria: severe-to-profound sensorineural loss in the better ear.
- Utilization was approximately 2.1% under expanded criteria including single-sided deafness or asymmetrical loss, with severe-to-profound loss in the worse ear.
- The authors state that the total population of untreated audiometric candidates continued to rise despite growth in the annual proportion receiving implants.
Limits
Only the publisher abstract was accessible and archived; the full article, funding statement, underlying market report and research sample size could not be assessed. The population estimates concern 2015 and audiometric eligibility, not present-day clinical candidacy or venue attendance. Implant devices and implant recipients have different counts.
Read the original
journals.lww.com/10.1097/MAO.0000000000003513
Cited in
Cite this source
Nassiri AM, Sorkin DL, Carlson ML. Current Estimates of Cochlear Implant Utilization in the United States. Otology & Neurotology 43(5):e558-e562 (Wolters Kluwer). June 2022. https://journals.lww.com/10.1097/MAO.0000000000003513 (accessed 13 October 2026).
Every finding here cites its source, and who funded each source is labelled. This site does not recommend products. Found an error or a missing study? Suggest a correction.